ExploreWatchlistsPricing
  1. JP-listed companies
  2. OLYMPUS CORPORATION
  3. Financials
  4. Total assets

OLYMPUS CORPORATION (7733)

Market cap
¥1.75T
P/E ratio
18.2x
Olympus manufactures medical endoscopes and therapeutic devices for hospitals and healthcare providers worldwide, specializing in gastrointestinal, surgical, and diagnostic equipment.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal assets (Million JPY)YoY (%)
Mar 31, 20251,432,826-6.61%
Mar 31, 20241,534,216+1.72%
Mar 31, 20231,508,308+11.07%
Mar 31, 20221,357,999+14.99%
Mar 31, 20211,181,017+16.28%
Mar 31, 20201,015,663+8.97%
Mar 31, 2019932,030-4.76%
Mar 31, 2018978,663-1.25%
Mar 31, 2017991,062-0.95%
Mar 31, 20161,000,614-7.48%
Mar 31, 20151,081,551

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat